Abstract
ROS1-rearranged non-small cell lung cancer (NSCLC) makes up approximately 1 to 2% of all NSCLC, is oncogenically driven by a constitutively activated ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
